Alaunos Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-12.3M | $-12.3M | $11.0K | $2.2M |
| FY2010 | $-19.7M | $-19.9M | $186.0K | $3.6M |
| FY2011 | $-38.8M | $-40.0M | $1.2M | $2.8M |
| FY2012 | $-78.8M | $-80.4M | $1.6M | $4.9M |
| FY2013 | $-59.5M | $-59.6M | $132.0K | $3.5M |
| FY2014 | $-36.7M | $-36.8M | $193.0K | $4.7M |
| FY2015 | $-10.0K | $-422.0K | $412.0K | $8.0M |
| FY2016 | $-58.3M | $-58.9M | $551.0K | $8.5M |
| FY2017 | $-54.7M | $-55.4M | $737.0K | $8.5M |
| FY2018 | $-49.5M | $-49.9M | $459.0K | $7.5M |
| FY2019 | $-40.9M | $-41.1M | $284.0K | $6.3M |
| FY2020 | $-57.0M | $-66.8M | $9.8M | $6.8M |
| FY2021 | $-61.5M | $-64.8M | $3.3M | $10.8M |
| FY2022 | $-29.2M | $-29.4M | $216.0K | $3.5M |
| FY2023 | $-30.1M | $-30.3M | $197.0K | $2.8M |
| FY2024 | $-5.0M | $-5.0M | $0 | $435.0K |
| FY2025 | $-2.9M | $-3.0M | $98.0K | $796.0K |